Table 3.
BBD Histologic Subtype and type and extent of atypia | Cases | Percent Ipsilateral* | Controls | OR (95% CI) |
---|---|---|---|---|
Non-proliferative | 108 | 51.3 | 680 | 1.0 (ref) |
Proliferative without atypia | 256 | 54.9 | 1035 | 1.6 (1.3-2.1) |
ADH, 1-2 foci | 37 | 61.3 | 75 | 3.5 (2.2-5.6) |
ADH, ≥3 foci | 15 | 69.2 | 41 | 2.7 (1.4-5.1) |
ALH, 1-2 foci | 19 | 52.6 | 25 | 5.2 (2.7-10.0) |
ALH, ≥3 foci | 32 | 57.7 | 26 | 8.0 (4.5-14.2) |
Among cases with available laterality data (N=387).
** Adjusted for matching factors (age at breast cancer diagnosis, year of benign breast biopsy, and time since BBD biopsy) and family history of breast cancer, age at menarche, parity/age at first birth, body mass index, menopausal status/type of menopause, and duration of postmenopausal hormone use.
Age-adjusted p-value for difference in laterality: ADH 1-2 vs. ≥3 foci, p=0.58; ALH 1-2 vs. ≥3 foci, p=0.66
p-het for breast cancer risk (not laterality):
p-het (age-adjusted), ADH 1-2 vs. ≥3 foci=0.41; p-het (age-adjusted), ALH 1-2 vs. ≥3 foci=0.19
p-trend (age-adjusted), number of AH foci among those with ADH = 0.54; p-trend (age-adjusted), number of AH foci among those with ALH = 0.24